MedPath

Coronary Artery Disease and Renal Failure Registry

Conditions
Coronary Artery Disease
Renal Failure
Registration Number
NCT00679419
Lead Sponsor
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
Brief Summary

It is the aim of the multi-centric and prospective registry to analyze in patients with CAD the impact of different grades of renal failure on the outcome and course of the patients and to correlate these with clinical variables.

In particular, the registry has the following objectives:

* prospective consecutive assessment of all patients with coronary artery disease and renal failure in the participating hospitals of the registry

* evaluation of the outcome and course of patients with regard to their different stages of renal failure at baseline

* analysis of the impact of different therapeutic strategies on acute and long-term outcomes

* identification of clinical risk factors, novel biomarkers and genetic markers for an unfavorable long-term outcome

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3352
Inclusion Criteria
  • Women and men >= 18 years of age
  • Patients with actually performed interventional coronary angiography and there a documented coronary heart disease, defined as at least one documented stenosis >= 50 % in at least one main coronary vessel (Main steam; RCX; RIVA; RCA)
  • European/Caucasian descent (European/Caucasian parents and grandparents)
  • Availability of an urine, serum- and EDTA blood sample of the patient
  • Documented consent of patients for handling of personal medical data, including a genetic analysis
Exclusion Criteria
  • Patients who have been already recruited into this registry
  • Patients with organ transplantations, apart from kidney transplantations
  • Immunosuppressive therapy, apart from immunosuppressive therapy after kidney transplantation
  • Patients with polycystic renal disease
  • Pregnant and breastfeeding patients
  • Known malignant tumor

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
all cause mortalitytwo years
Secondary Outcome Measures
NameTimeMethod
manner of deathtwo years

cardiac death; non-cardiac death; death of unknown cause

Trial Locations

Locations (32)

Josephs-Hospital Warendorf

🇩🇪

Warendorf, Germany

Zentralklinik Bad Berka

🇩🇪

Bad Berka, Germany

Universitätsklinikum Aachen

🇩🇪

Aachen, Germany

Schüchtermann-Klinik

🇩🇪

Bad Rothenfelde, Germany

Klinikum Lippe-Detmold

🇩🇪

Detmold, Germany

Herzzentrum Duisburg

🇩🇪

Duisburg, Germany

Evangelisches Krankenhaus Düsseldorf

🇩🇪

Düsseldorf, Germany

Universitätsklinikum Halle/Saale

🇩🇪

Halle/Saale, Germany

Klinikum Garmisch-Partenkirchen

🇩🇪

Garmisch-Partenkirchen, Germany

Alfried Krupp Krankenhaus Essen

🇩🇪

Essen, Germany

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Evangelisches Krankenhaus Hamm

🇩🇪

Hamm, Germany

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

SLK-Kliniken Heilbronn GmbH

🇩🇪

Heilbronn, Germany

St. Marienhospital Hamm

🇩🇪

Hamm, Germany

Privatklinik Dr. Schindlbeck

🇩🇪

Herrsching, Germany

Herzzentrum Lahr

🇩🇪

Lahr, Germany

Kardiologische Praxis Dr. Schön

🇩🇪

Mühldorf, Germany

Raphaelsklinik Münster

🇩🇪

Münster, Germany

Klinik Augustium München

🇩🇪

München, Germany

Klinikum Neuperlach

🇩🇪

München, Germany

Universitätsklinikum Münster

🇩🇪

Münster, Germany

St. Franziskus-Hospital

🇩🇪

Münster, Germany

Lukaskrankenhaus Neuss

🇩🇪

Neuss, Germany

Klinikum Pirna

🇩🇪

Pirna, Germany

St. Vincenz-Krankenhaus

🇩🇪

Paderborn, Germany

Euregioclinic Nordhorn

🇩🇪

Nordhorn, Germany

Christliches Krankenhaus Quakenbrück e.V.

🇩🇪

Quakenbrück, Germany

Zentralklinikum Suhl

🇩🇪

Suhl, Germany

Herzzentrum Brandenburg

🇩🇪

Brandenburg, Germany

St.-Vincenz-Hospital

🇩🇪

Coesfeld, Germany

Herz- und Gefäßklinik Bad Neustadt

🇩🇪

Bad Neustadt, Germany

© Copyright 2025. All Rights Reserved by MedPath